Deep Health AI India Limited (BOM:539559)
India · Delayed Price · Currency is INR 1.940
-0.010 (-0.51%)
At close: Aug 21, 2026
Deep Health AI India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 280 | 274 | 215 | 284 | 539 | 46 | |
Market Cap Growth | 35.35% | 27.23% | -24.20% | -47.28% | 1069.74% | 4.66% |
Enterprise Value | 191 | 244 | 188 | 307 | 467 | 44 |
Last Close Price | 1.94 | 1.90 | 4.09 | 5.39 | 10.23 | 1.31 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 24.15 | 24.56 | 68.13 | 42.88 | 23.37 |
PS Ratio | 6.15 | 6.44 | 17.09 | 11.11 | 7.02 | 3.31 |
PB Ratio | 0.54 | 0.53 | 0.96 | 1.39 | 3.66 | 0.60 |
P/TBV Ratio | 0.54 | 0.53 | 0.96 | 1.39 | 3.66 | 0.60 |
P/FCF Ratio | - | - | 114.96 | - | - | 8.88 |
P/OCF Ratio | - | - | 114.36 | - | 2669.38 | 8.88 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.21 | 5.75 | 14.93 | 12.03 | 6.09 | 3.19 |
EV/EBITDA Ratio | 20.35 | 7.33 | 41.23 | - | 28.91 | 1595.14 |
EV/EBIT Ratio | 20.51 | 7.35 | 42.26 | - | 29.03 | 3763.86 |
EV/FCF Ratio | - | - | 100.41 | - | - | 8.56 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.08 | 0.26 | - |
Debt / EBITDA Ratio | 0.28 | 0.11 | 1.33 | - | 2.39 | - |
Debt / FCF Ratio | - | - | 3.25 | - | - | - |
Net Debt / Equity Ratio | -0.17 | -0.17 | -0.12 | -0.08 | -0.15 | -0.13 |
Net Debt / EBITDA Ratio | -6.74 | -2.65 | -5.95 | 7.21 | -1.33 | -362.71 |
Net Debt / FCF Ratio | - | 2.42 | -14.50 | 0.31 | 87.16 | -1.95 |
Asset Turnover | - | 0.11 | 0.05 | 0.12 | 0.56 | 0.18 |
Inventory Turnover | - | - | 0.25 | 1.06 | 2.15 | 0.28 |
Quick Ratio | - | 17.02 | 2.54 | 1.85 | 1.69 | 24.33 |
Current Ratio | - | 19.34 | 3.15 | 2.20 | 1.92 | 76.42 |
Return on Equity (ROE) | - | 3.08% | 4.10% | 2.37% | 11.21% | 2.60% |
Return on Assets (ROA) | - | 5.47% | 1.18% | -0.72% | 7.29% | 0.01% |
Return on Invested Capital (ROIC) | 3.06% | 7.60% | 1.82% | -1.14% | 12.12% | 0.01% |
Return on Capital Employed (ROCE) | - | 6.50% | 2.00% | -1.20% | 10.90% | 0.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -3.85% | 4.14% | 4.07% | 1.47% | 2.33% | 4.28% |
FCF Yield | -13.06% | -13.34% | 0.87% | -19.10% | -0.05% | 11.26% |
Payout Ratio | - | 127.13% | - | - | - | - |
Buyback Yield / Dilution | -117.04% | -96.65% | - | - | -50.16% | - |